BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,995,000 | -31.8% | 10,982,000 | -18.7% | 0.02% | -50.0% |
| Q2 2017 | $16,124,000 | -24.6% | 13,500,000 | -25.2% | 0.03% | -25.0% |
| Q1 2017 | $21,385,000 | +17.0% | 18,037,000 | +16.1% | 0.04% | +8.1% |
| Q4 2016 | $18,285,000 | -2.6% | 15,537,000 | +3.6% | 0.04% | 0.0% |
| Q3 2016 | $18,778,000 | +256.7% | 15,000,000 | +200.0% | 0.04% | +236.4% |
| Q2 2014 | $5,265,000 | +3071.7% | 5,000,000 | +3233.3% | 0.01% | – |
| Q1 2014 | $166,000 | +3.8% | 150,000 | 0.0% | 0.00% | – |
| Q4 2013 | $160,000 | – | 150,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 5,000,000 | $5,003,000 | 2.71% |
| Weiss Asset Management LP | 65,841,000 | $64,360,000 | 2.62% |
| Davide Leone & Partners Investment Co Ltd. | 10,500,000 | $10,513,000 | 1.19% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,597,000 | $29,800,000 | 1.14% |
| GLAZER CAPITAL, LLC | 7,483,000 | $7,474,000 | 0.36% |
| BLUEFIN CAPITAL MANAGEMENT, LLC | 52,500 | $5,243,000 | 0.33% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,428,000 | $13,444,000 | 0.29% |
| CSS LLC/IL | 5,500,000 | $5,498,000 | 0.26% |
| Kohlberg Kravis Roberts & Co. L.P. | 40,182,000 | $40,159,000 | 0.23% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,606,000 | $2,606,000 | 0.10% |